This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday – Avidity Biosciences (NASDAQ:RNA), Radiopharm Theranostics (NASDAQ:RADX)

Mar 12, 2025
this-s&p-global-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-wednesday-–-avidity-biosciences-(nasdaq:rna),-radiopharm-theranostics-(nasdaq:radx)

Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • BMO Capital analyst Kostas Biliouris initiated coverage on Avidity Biosciences, Inc. RNA with an Outperform rating and announced a price target of $72. Avidity Biosciences shares closed at $29.58 on Tuesday. See how other analysts view this stock.
  • B. Riley Securities analyst Yuan Zhi initiated coverage on Radiopharm Theranostics Limited RADX with a Buy rating and announced a price target of $15. Radiopharm Theranostics shares closed at $5.75 on Tuesday. See how other analysts view this stock.
  • Morgan Stanley analyst David Arcaro initiated coverage on Talen Energy Corporation TLN with an Overweight rating and announced a price target of $243. Talen Energy shares closed at $176.56 on Tuesday. See how other analysts view this stock.
  • Mizuho analyst Sean Kennedy initiated coverage on S&P Global Inc. SPGI with an Outperform rating and announced a price target of $599. S&P Global shares closed at $480.00 on Tuesday. See how other analysts view this stock.
  • Scotiabank analyst Nat Schindler initiated coverage on Upwork Inc. UPWK with a Sector Perform rating and announced a price target of $15. Upwork shares closed at $13.39 on Tuesday. See how other analysts view this stock.

Considering buying SPGI stock? Here’s what analysts think:

Read this Next:

Don’t miss a beat on the share market. Get real-time updates on top stock movers and trading ideas on Benzinga India Telegram channel.

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Leave a comment